ABSTRACT
Every day Pharmaceutical and Biotechnology companies face safety reporting challenges as new regulations gain momentum. Current case study is about achieving a Regulatory milestone (E2B (R2) compliant format) crucial for pharmacovigilance submissions to Regulatory Agencies